ArticleClinical Medicine Insights. Oncology2026

Efficacy and Safety Ranking of HER2-Targeted TKIs in Advanced Breast Cancer: A Bayesian Network Meta-Analysis.

Rongjie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.